Work at NKW ImmunityBio Inc.

ImmunityBio is a commercial-stage biotechnology company developing immunotherapy and cell therapy platforms aimed at treating cancer and infectious diseases. Its lead commercial product is ANKTIVA, and the company also develops related immune-based therapies and...

Healthcare Health Care Health Diagnostics Oncology Therapeutics

Open roles 8

Founded 2014

Type Public · IBRX

Team size 501–1,000

Headquarters Dunkirk

Website immunitybio.com

Legal name NantBioCell LLC

View on LinkedIn →

Open roles at NKW ImmunityBio Inc

8 open roles

Senior Backend Software Architect El Segundo CA Mariposa · El Segundo CA Mariposa Salary TBC 6 days ago

Senior Analyst, ERP Systems El Segundo CA Mariposa · El Segundo CA Mariposa Salary TBC 19 days ago

Veeva Clinical Analyst Dunkirk · Dunkirk Salary TBC 25 days ago

BioProcess Engineer II, Upstream Louisville · Louisville Salary TBC 33 days ago

BioProcess Engineer II, Downstream Louisville · Louisville Salary TBC 33 days ago

DevOps Engineer El Segundo CA Mariposa · El Segundo CA Mariposa Salary TBC 62 days ago

Senior, IT GXP Systems Specialist El Segundo CA Mariposa · El Segundo CA Mariposa Salary TBC 76 days ago

Workday Analyst United Kingdom · United Kingdom Salary TBC 82 days ago

About NKW ImmunityBio Inc

Products & services

ANKTIVA® (nogapendekin alfa inbakicept-pmln) An IL-15 receptor agonist immunotherapy used with BCG for adults with BCG-unresponsive non-muscle-invasive bladder cancer with carcinoma in situ, with or without papillary tumors.
Natural Killer (NK) Cell Therapy Platform A platform of off-the-shelf natural killer cell therapies, including aNK, haNK, taNK and related CAR-NK approaches, for investigational cancer and infectious-disease treatment.
Cancer Vaccine Platform A vaccine development platform using second-generation human adenovirus and yeast technologies to generate cellular and antibody immune responses against cancer or infectious diseases.
QUILT Clinical Development Platform A clinical research platform for evaluating combinations of vaccines, immunotherapies, cell therapies, cytokines and other treatments across cancer and infectious-disease indications.
NK-92® Research Cell Lines and Bioanalytical Tools Research-grade NK-92 natural killer cell lines used in laboratory assays for evaluating antibody-dependent cellular cytotoxicity, cytokine activity and other immune-cell functions.
Expanded Access Program A physician-requested pathway for eligible patients with serious or life-threatening disease to seek access to certain investigational ImmunityBio medicines outside clinical trials.

Leadership

Patrick Soon-Shiong Founder and Executive Chairman
Jim Kim Vice Chairman
Barry Simon Director & Chief Corporate Affairs Officer
Sarah Singleton Chief Communications Officer

Seniority mix

Entry & junior 1 role
Mid-level 2 roles
Senior 3 roles
Lead & principal 0 roles
Manager & above 1 role

Based on 7 open roles

Where they hire

El Segundo CA Mariposa, ON 3 roles
Louisville, CO 2 roles
Dunkirk, NY 1 role

Remote: 2 roles

Based on 6 roles with a listed city

Brands & subsidiaries

VivaBioCell

Work at NKW ImmunityBio Inc.

Open roles at NKW ImmunityBio Inc

Subscribe to Career Resources.

Your cookie choices